Skip to main content
SpringerLink
Log in

Re-testing HIV-positive patients before ART saves costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. US dollars

Reference

  • Eaton JW, et al. The cost of not re-testing: HIV misdiagnosis in the ART 'test-and-offer' era. Clinical Infectious Diseases : 24 Apr 2017. Available from: URL: http://doi.org/10.1093/cid/cix341

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Re-testing HIV-positive patients before ART saves costs. PharmacoEcon Outcomes News 777, 29 (2017). https://doi.org/10.1007/s40274-017-3968-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3968-x

Search

Navigation